Text Size
33 studies found for:    "Anthrax"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Recruiting Ciprofloxacin BioThrax Co-Administration Study
Condition: Anthrax
Interventions: Biological: BioThrax;   Drug: Ciprofloxacin
22 Terminated Ph1 Study of Valortim and Doxycycline in Humans
Condition: Anthrax
Interventions: Drug: Doxycycline and Valortim;   Drug: Placebo Antibiotic and Valortim;   Drug: Placebo Antibiotic and Placebo Valortim
23 Active, not recruiting Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects
Condition: Anthrax
Interventions: Drug: Normal Saline for Injection;   Biological: MDX1303
24 Suspended Ph1 Study of Valortim and Ciprofloxacin in Humans
Condition: Anthrax
Interventions: Drug: Ciprofloxacin and Valortim;   Drug: Placebo Antibiotic and Valortim;   Other: Placebo Antibiotic and Placebo Valortim
25 Completed Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9)
Condition: Anthrax
Interventions: Drug: AVP-21D9;   Drug: Placebo
26 Completed VHA Clinicians and Bioterror Events: Interactive Web-based Learning
Conditions: Smallpox;   Anthrax
Intervention: Behavioral: BioCASES and BioTESTS
27 Completed CDC Anthrax Vaccine Clinical Trial
Condition: Healthy
Intervention: Biological: BioThrax or Anthrax Vaccine Adsorbed
28 Recruiting BioThrax (Anthrax Vaccine Adsorbed) Vaccine in Pregnancy Registry
Conditions: Pregnancy Complications;   Pregnancy Outcome;   Congenital Abnormalities
Intervention: Biological: Observational Intervention
29 Completed Glyburide Advantage in Malignant Edema and Stroke Pilot
Condition: Ischemic Stroke
Intervention: Drug: RP-1127 (Glyburide for injection)
30 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Anesthesia;   Pain;   Reflux
Intervention: Drug: Ampicillin
31 Completed Assessment of the Safety and Efficacy of Ciproxan-I.V. in Daily Clinical Practice - Analysis Results From a Post-marketing Surveillance
Condition: Infection
Intervention: Drug: Ciprofloxacin (BAYQ3939)
32 Completed Ciprofloxacin Special Drug Use Investigation - To Investigate the Safety and Efficacy in Patients With Ciprofloxacin iv Administration Without Dilution
Condition: Infection
Intervention: Drug: Cipro (Ciprofloxacin, BAYQ3939)
33 Completed A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine LFn-p24 Administered by the Intramuscular (IM) Route in Healthy Adults
Condition: HIV Infections
Intervention: Biological: HIV LFn-p24
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-33) Next Page
† Indicates status has not been verified in more than two years